Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ASTELLAS-PHARMA-INC-6491262/news/Astellas-Pharma-ENZALUTAMIDE-XTANDI-NOW-APPROVED-IN-EUROPE-FOR-THE-TREATMENT-OF-MEN-WITH-METASTA-19478076/?utm_source=whatsapp&utm_medium=social&utm_campaign=share